Based on review of available evidence, FDA has concluded that using an infusion pump connected to a nebulizer for tracheal delivery of nebulized medications allows for prolonged treatment with these medications, while risks to patients are the same as for other routes of administration.
Additional information can be obtained at https://www.fda.gov/media/136894/download.